Purchase Order 75N98026P00928
Award Date 7/8/26
Potential Completion Date 7/7/27
Potential Value $347K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Human Genome Research Institute (NHGRI) has awarded a $198,082.98 firm fixed-price purchase order to Pacific Biosciences of California, Inc. for Revio Single Molecule Real-Time (SMRT) cells and sequencing reagents. This new award, announced on September 16, 2025, with an ultimate completion date of September 26, 2026, represents a direct procurement of specialized laboratory consumables essential for advanced genomic sequencing operations. The contract carries no set-aside...
- This $274,176 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Pacific Biosciences of California, Inc., a for-profit manufacturer. The contract is for the delivery of PacBio Revio sequencing reagents, which support the agency's genomic research initiatives. Pacific Biosciences is the original equipment manufacturer for the proprietary PacBio Sequel and Sequel II DNA/RNA sequencing...
- <p>The National Human Genome Research Institute awarded a $220,000 purchase order to Pacific Biosciences of California, Inc. on April 18, 2019 for a PacBio Sequel System 8M upgrade. Work is performed in Menlo Park, California, with an ultimate completion date of October 31, 2019. The order uses firm fixed-price pricing with no small business set-aside.</p>
- This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Pacific Biosciences of California, Inc. for the delivery of REVIO SPRQ REAGENT KIT. The contract has a ceiling value of $137,088.00 and a period of performance through February 28, 2025. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by various federal agencies to...
- <p>The National Human Genome Research Institute issued a purchase order to Pacific Biosciences of California, Inc. on October 8, 2020, with a ceiling value of $23,531.00 to perform high-throughput, large-scale DNA sequencing and sequence analysis. Work is performed in Menlo Park, California. The order carries firm fixed-price pricing and has an ultimate completion date of December 8, 2020.</p>
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Pacific Biosciences of California, Inc. valued at $85,000 on July 25, 2026, for state-of-the-art sequencing services using PacBio Revio technology. Performance occurs in Menlo Park, California. The order provides highly accurate long-read sequence data critical for certain experimental types across NIH institutes. The purchase order carries firm fixed-price pricing with an ultimate completion date of July 25, 2027.</p>
- This is a $85,000.00 firm-fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI) to Pacific Biosciences of California, Inc. for a service contract to provide the Pacific Biosciences Revio, a new sequencing system. The contract has an ultimate completion date of July 31, 2026. Pacific Biosciences is a for-profit biotechnology company that specializes in advanced DNA and RNA sequencing technologies. This contract is not a set-aside. Pacific...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed-price purchase order contract to Pacific Biosciences of California, Inc. to provide SEQUEL II SEQUENCING KIT 2.0 BUNDLE. The contract has a potential value of $118,381.00 and a completion date of December 31, 2022. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services for DNA/RNA sequencing systems. The company has...
- This federal contract award to Pacific Biosciences of California, Inc. is for the procurement of PacBio Revio Sequencer Systems by the National Human Genome Research Institute (NHGRI), a component of the U.S. Department of Health and Human Services. The contract has a ceiling value of $540,088.00 and is a firm fixed-price purchase order with an ultimate completion date of August 12, 2024. The award was made on June 26, 2024, and there was no set-aside designation used. Pacific Biosciences is a...
- <p>The National Human Genome Research Institute awarded a purchase order to Pacific Biosciences of California, Inc. for $10,208.00 on April 30, 2021, for SEQUEL II SEQUENCING KIT 2.0 BDLE (5-PK).</p> <p>Performance is located in North Bethesda, Maryland. The order carried a firm fixed price and was completed on April 30, 2021. No set-aside applied.</p>